These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26341649)

  • 1. Current treatment options for idiopathic angioedema.
    Shroba J; Hanson J; Portnoy J
    Ann Allergy Asthma Immunol; 2015 Nov; 115(5):429-33. PubMed ID: 26341649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icatibant for the treatment of hereditary angioedema.
    Cole SW; Lundquist LM
    Ann Pharmacother; 2013 Jan; 47(1):49-55. PubMed ID: 23249729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Treatment of Non-hereditary Angioedema.
    van den Elzen M; Go MFCL; Knulst AC; Blankestijn MA; van Os-Medendorp H; Otten HG
    Clin Rev Allergy Immunol; 2018 Jun; 54(3):412-431. PubMed ID: 27672078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novelties in the Diagnosis and Treatment of Angioedema.
    Cicardi M; Suffritti C; Perego F; Caccia S
    J Investig Allergol Clin Immunol; 2016; 26(4):212-21; quiz two pages after page 221. PubMed ID: 27470642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic nonhistaminergic angioedema successfully treated with ecallantide, icatibant, and C1 esterase inhibitor replacement.
    Stahl MC; Harris CK; Matto S; Bernstein JA
    J Allergy Clin Immunol Pract; 2014; 2(6):818-9. PubMed ID: 25439384
    [No Abstract]   [Full Text] [Related]  

  • 6. Angioedema: etiology, pathophysiology, current and emerging therapies.
    Lewis LM
    J Emerg Med; 2013 Nov; 45(5):789-96. PubMed ID: 23992848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of novel therapies for acute hereditary angioedema.
    Firszt R; Frank MM
    Am J Clin Dermatol; 2010 Dec; 11(6):383-8. PubMed ID: 20866113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Therapies for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Systematic Review of Current Evidence.
    Riha HM; Summers BB; Rivera JV; Van Berkel MA
    J Emerg Med; 2017 Nov; 53(5):662-679. PubMed ID: 28939396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.
    Cicardi M; Banerji A; Bracho F; Malbrán A; Rosenkranz B; Riedl M; Bork K; Lumry W; Aberer W; Bier H; Bas M; Greve J; Hoffmann TK; Farkas H; Reshef A; Ritchie B; Yang W; Grabbe J; Kivity S; Kreuz W; Levy RJ; Luger T; Obtulowicz K; Schmid-Grendelmeier P; Bull C; Sitkauskiene B; Smith WB; Toubi E; Werner S; Anné S; Björkander J; Bouillet L; Cillari E; Hurewitz D; Jacobson KW; Katelaris CH; Maurer M; Merk H; Bernstein JA; Feighery C; Floccard B; Gleich G; Hébert J; Kaatz M; Keith P; Kirkpatrick CH; Langton D; Martin L; Pichler C; Resnick D; Wombolt D; Fernández Romero DS; Zanichelli A; Arcoleo F; Knolle J; Kravec I; Dong L; Zimmermann J; Rosen K; Fan WT
    N Engl J Med; 2010 Aug; 363(6):532-41. PubMed ID: 20818888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitor-induced angioedema.
    Baram M; Kommuri A; Sellers SA; Cohn JR
    J Allergy Clin Immunol Pract; 2013; 1(5):442-5. PubMed ID: 24565614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of patients with angioedema without wheals: the importance of F12 gene screening.
    Firinu D; Bafunno V; Vecchione G; Barca MP; Manconi PE; Santacroce R; Margaglione M; Del Giacco SR
    Clin Immunol; 2015 Apr; 157(2):239-48. PubMed ID: 25744496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic management of angioedema induced by angiotensin-converting enzyme inhibitors.
    Scalese MJ; Reinaker TS
    Am J Health Syst Pharm; 2016 Jun; 73(12):873-9. PubMed ID: 27261237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tranexamic acid as first-line emergency treatment for episodes of bradykinin-mediated angioedema induced by ACE inhibitors].
    Beauchêne C; Martins-Héricher J; Denis D; Martin L; Maillard H
    Rev Med Interne; 2018 Oct; 39(10):772-776. PubMed ID: 29735174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradykinin-mediated diseases.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary angioedema: management of laryngeal attacks.
    Christiansen SC; Zuraw BL
    Am J Rhinol Allergy; 2011; 25(6):379-82. PubMed ID: 22185739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED.
    Bartal C; Zeldetz V; Stavi V; Barski L
    Am J Emerg Med; 2015 Mar; 33(3):479.e1-3. PubMed ID: 25241359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of drugs-associated non-hereditary angioedema mediated by bradykinin].
    Muller Y; Harr T
    Rev Med Suisse; 2016 Jan; 12(500):11-2. PubMed ID: 26946694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with icatibant in the management of drug induced angioedema.
    Bertazzoni G; Bresciani E; Cipollone L; Fante E; Galandrini R
    Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):149-53. PubMed ID: 25635988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency.
    Zanichelli A; Mansi M; Periti G; Cicardi M
    Expert Rev Clin Immunol; 2013 May; 9(5):477-88. PubMed ID: 23634741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acquired angioedema due to C1-inhibitor deficiency: CREAK recommendations for diagnosis and treatment].
    Gobert D; Bouillet L; Armengol G; Coppo P; Defendi F; Du-Thanh A; Hardy G; Javaud N; Jeandel PY; Launay D; Panayotopoulos V; Pelletier F; Boccon-Gibod I; Fain O
    Rev Med Interne; 2020 Dec; 41(12):838-842. PubMed ID: 32753245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.